Medicenna Therapeutics Corp. Equity
Medicenna Therapeutics Corp. (MDNAF) had Equity of CAD 29.49 million as of 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes
ifrs-full:Equity · last filed 2023-06-27
- 2023-03-31: Equity 29.49M CAD.
- 2022-03-31: Equity 20.84M CAD.
- 2021-03-31: Equity 38.15M CAD.
- 2020-03-31: Equity 36.15M CAD.
| Period end | Equity |
|---|---|
| 2023-03-31 | 29.49M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | 20.84M CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | 38.15M CAD 20-F · filed 2023-06-27 |
| 2020-03-31 | 36.15M CAD 20-F · filed 2023-06-27 |
| 2019-03-31 | 2.62M CAD 20-F · filed 2022-06-22 |